Retrospective analysis of the safety and effectiveness of immune checkpoint inhibitors in mucosal melanoma patients

被引:0
|
作者
Hanamura, Fumiyasu [1 ]
Fuchizaki, Youji [1 ]
Nishijima, Tomohiro [1 ]
Komoda, Masato [1 ]
Esaki, Taito [1 ]
机构
[1] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
关键词
D O I
10.1016/j.annonc.2022.05.244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P9-8
引用
收藏
页码:S516 / S516
页数:1
相关论文
共 50 条
  • [41] Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
    Tiu, Bruce C.
    Strohbehn, Ian A.
    Zhao, Sophia
    Ouyang, Tianqi
    Hanna, Paul
    Wang, Qiyu
    Gupta, Shruti
    Leaf, David E.
    Reynolds, Kerry L.
    Sise, Meghan E.
    ONCOLOGIST, 2023, 28 (06): : E379 - E390
  • [42] Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
    Reid, Pankti
    Sandigursky, Sabina
    Song, Juhee
    Lopez-Olivo, Maria A.
    Safa, Houssein
    Cytryn, Samuel
    Efuni, Elizaveta
    Buni, Maryam
    Pavlick, Anna
    Krogsgaard, Michelle
    Abu-Shawer, Osama
    Altan, Mehmet
    Weber, Jeffrey S.
    Rahma, Osama E.
    Suarez-Almazor, Maria E.
    Diab, Adi
    Abdel-Wahab, Noha
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [43] Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study
    Galmiche, S.
    Lheure, C.
    Kramkimel, N.
    Franck, N.
    Boitier, F.
    Dupin, N.
    Turc, G.
    Psimaras, D.
    Aractingi, S.
    Guegan, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (12) : E440 - E443
  • [44] Real-world effectiveness of immune checkpoint inhibitors and BRAF/ MEK inhibitors among veteran patients with cutaneous melanoma
    Kim, Daniel Y.
    Swetter, Susan M.
    Huhmann, Linden
    Dizon, Matthew P.
    Ferguson, Jacqueline M.
    Osborne, Thomas F.
    Spence, Allyson C.
    Ziad, Amina
    Fillmore, Nathanael
    Hartman, Rebecca I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 620 - 623
  • [45] The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
    Li, Ping
    Yang, Xuefang
    Feng, Yumiao
    Wu, Lijuan
    Ma, Wei
    Ding, Gaozhong
    Wei, Yun
    Sun, Lan
    ONCOTARGETS AND THERAPY, 2018, 11 : 7521 - 7527
  • [46] EFFECTIVENESS AND UTILIZATION OF FIRST-LINE IMMUNE CHECKPOINT INHIBITORS FOR PATIENTS WITH EXTRACRANIAL & INTRACRANIAL METASTATIC MELANOMA
    Lamba, Nayan
    Iorgulescu, Bryan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A265 - A266
  • [47] Outcomes after retreatment with MAPK inhibitors and immune checkpoint inhibitors in melanoma patients
    Persa, Oana D.
    Mauch, Cornelia
    FUTURE ONCOLOGY, 2021, 17 (29) : 3809 - 3817
  • [48] Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma
    Rosner, Samuel
    Agrawal, Yuri
    Sun, Daniel Q.
    Aygun, Nafi
    Schollenberger, Megan D.
    Lipson, Evan
    Naidoo, Jarushka
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [49] COST-EFFECTIVENESS ANALYSIS OF IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF ADVANCED MELANOMA: A SYSTEMATIC LITERATURE REVIEW
    Chang, C. Y.
    Malone, D.
    VALUE IN HEALTH, 2019, 22 : S68 - S68
  • [50] Safety of Immune Checkpoint Inhibitors for the Treatment of Melanoma, Bronchopulmonary and Urologic Neoplasms in Patients with Preexisting Autoimmune Disease
    Tison, Alice
    Quere, Gilles
    Misery, Laurent
    Lesimple, Thierry
    Marcq, Marie
    Martinez, Stephanie
    Brunet-Possenti, Florence
    Mansard, Sandrine
    Beneton, Nathalie
    Lambert, Mickael
    Roge, Christophe
    Zehou, Ouidad
    Aubin, Francois
    Maanaoui, Sarah
    Scalbert, Camille
    Giacchero, Damien
    Kramkimel, Nora
    Skowron, Francois
    Pham-Ledard, Anne
    Cornec, Divi
    Kostine, Marie
    ARTHRITIS & RHEUMATOLOGY, 2017, 69